Maslov M Y
Tufts University School of Medicine, USA
Biography
Mikhail Maslov has done his PhD and has been in biomedical research for 20 years. He is an expert in local myocardial drug delivery, infusion systems, cardiovascular pharmacology, heart failure and hemorheology. He has investigated myocardial pharmacokinetics and pharmacodynamics following epicardial drug delivery and evaluated role of compromised myocardial energy metabolism in the development of heart failure. He has contributed to the global pre-clinical studies of Entresto, a new drug designed to treat heart failure.